- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00194558
Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes Care
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
We will conduct a 12-month randomized controlled trial comparing usual care versus chronic disease management using the Internet among patients with type 1 diabetes on multiple daily injections with insulin glargine and rapid-acting analogs. Specifically, the objectives of the study are to:
- Evaluate the difference in glycemic control (HbA1c) between intervention and control,
- Evaluate the difference in resource utilization and costs of care between intervention and control, and
- Evaluate the difference in satisfaction with care between intervention and control.
A total of 80-85 subjects will be recruited from patients receiving care in the Diabetes Care Center (DCC) at the University of Washington in Seattle. As part of a pretest-posttest experimental design, intervention-group subjects will be trained in the use of an existing diabetes disease-management module comprising six related Web sites that are accessed from home via links displayed within the University's "MyUW" Internet portal. These sites allow patients to:
- View their entire electronic medical record including clinical reminders, the same record used by providers,
- Upload blood glucose readings stored in a digital meter,
- Manually enter medication, nutrition, and exercise data into an online daily diary,
- Communicate with providers regarding treatment recommendations or other questions using a clinical e-mail service,
- Obtain additional information from a traditional education site whose content and links were sanctioned by the Medical Director of the DCC, and
- Employ a second education site to collaboratively generate action plans intended to enhance self-efficacy.
In addition to login and password protection, access to confidential information from home requires the use of secondary authentication (SecureID). All clinical and other data can be viewed by patients and providers in online trended displays that will be used by a nurse practitioner to review cases no less than weekly. As the control group, subjects receiving usual care will not have access to the diabetes module and related case-management services being evaluated.
The primary clinical outcome for the study is the between group differences in glycemic control using HbA1c as the metric. A co-primary outcome is all direct medical care utilization. Satisfaction with diabetes care, employing both a quantitative survey (Patient Assessment of Chronic Illness Care) and semi-structured interviews performed on a 20% purposive sub-sample of intervention patients, is a secondary outcome measure.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Washington
-
Seattle, Washington, Forenede Stater, 98195
- University of Washington, Diabetes Care Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Computer and Internet access at home
- Receiving care at the University of Washington Diabetes Care Center
Exclusion Criteria:
- Non-English speaking
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
---|
Hæmoglobin A1c
|
Sekundære resultatmål
Resultatmål |
---|
Utilization
|
Tilfredshed med omsorg
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Harold I Goldberg, MD, University of Washington
Datoer for undersøgelser
Studer store datoer
Studiestart
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 04-3892-G-01
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Diabetes mellitus, type 1
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.AfsluttetDiabetes mellitus, type 1 | Type 1 diabetes | Diabetes type 1 | Type 1 diabetes mellitus | Autoimmun diabetes | Diabetes mellitus, insulinafhængig | Juvenil-Debut Diabetes | Diabetes, autoimmun | Insulinafhængig diabetes mellitus 1 | Diabetes mellitus, insulinafhængig, 1 | Diabetes mellitus, skør | Diabetes Mellitus... og andre forholdForenede Stater
-
University of California, San FranciscoJuvenile Diabetes Research FoundationAfsluttetType 1 diabetes mellitus | Diabetes mellitus, type I | Insulinafhængig diabetes mellitus 1 | Diabetes mellitus, insulinafhængig, 1 | IDDMForenede Stater, Australien
-
Capillary Biomedical, Inc.AfsluttetDiabetes mellitus, type 1 | Type 1 diabetes | Type 1 diabetes mellitus | Diabetes mellitus, insulinafhængig, 1Australien
-
Spiden AGDCB Research AGRekrutteringType 1 diabetes mellitus | Type 1 diabetes mellitus med hypoglykæmi | Type 1 diabetes mellitus med hyperglykæmiSchweiz
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)AfsluttetType 1 diabetes mellitus | T1DM | T1D | Nyopstået type 1-diabetes mellitusForenede Stater, Australien
-
Capillary Biomedical, Inc.AfsluttetType 1 diabetes | Type 1 diabetes mellitus | Diabetes mellitus, type I | Diabetes mellitus, insulinafhængig, 1 | IDDMØstrig
-
Instytut Diabetologii Sp. z o.o.National Center for Research and Development, Poland; Nalecz Institute...UkendtType 1 diabetes mellitus med hyperglykæmi | Type 1 diabetes mellitus med hypoglykæmiPolen
-
National Institute of Diabetes and Digestive and...AfsluttetDiabetes mellitus type 1Forenede Stater
-
Stem Cells ArabiaAfsluttetGlukosemetabolismeforstyrrelser | Metaboliske sygdomme | Sygdomme i immunsystemet | Autoimmune sygdomme | Sygdomme i det endokrine system | Diabetes mellitus type 1Jordan
-
Shanghai Changzheng HospitalRekrutteringSkør type 1 diabetes mellitusKina
Kliniske forsøg med Internet co-management modul
-
Robert Wood Johnson FoundationAfsluttetDiabetes mellitus, type 2Forenede Stater
-
University of WashingtonCenter for Health Management ResearchAfsluttetCyber Disease Management: Using the World Wide Web to Share the Medical Record With Patients at HomeDiabetes mellitus, type 2Forenede Stater
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenAfsluttetHjerte-kar-sygdomme | Delirium | Skrøbelige ældre | Dagliglivets aktiviteter | Geriatrisk vurdering | Opholdsvarighed | Sundhedstjenester for ældreBelgien
-
Dana-Farber Cancer InstituteRekrutteringMavekræft | Kræft i bugspytkirtlen | Spiserørskræft | Endetarmskræft | Tyktarmskræft | Gastrointestinal kræftForenede Stater
-
Memorial Sloan Kettering Cancer CenterAfsluttet
-
Dana-Farber Cancer InstituteAfsluttetHæmatologisk malignitetForenede Stater
-
University of California, San DiegoPatient-Centered Outcomes Research Institute; University of California,... og andre samarbejdspartnereIkke rekrutterer endnu
-
University of California, San DiegoUniversity of California, Los Angeles; Cedars-Sinai Medical Center; RAND; Agency... og andre samarbejdspartnereRekrutteringUfrivillig vandladningForenede Stater
-
Institute FranciAktiv, ikke rekrutterendeRehabilitering af tandløs område med et implantatniveauItalien
-
Cairo UniversityAfsluttetBilateral cerebral pareseEgypten